CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SRPT

AVI-4658 (Eteplirsen)

Phase 2
Sarepta Therapeutics, Inc. (SRPT)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

3 competitors in Duchenne Muscular Dystrophy (DMD)

View Full Landscape
Drug Information

Target Indication

Duchenne Muscular Dystrophy (DMD)

Clinical Trial

NCT01540409

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.